Get started
Author

Julia Fountain

Observed names: Fountain, Julia, J. Fountain, Julia C. Fountain
ORCID: 0000-0001-6316-8976
Observed ORCID: 0000-0001-6316-8976
OpenAlex ID: A5045477350
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
2020 · Juan M. Arriaga, Sukanya Panja, et al. · Nature Cancer · 78
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer
2020 · Laura A. Sena, Julia Fountain, et al. · The Oncologist · 61
PDF
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
2020 · C. Lu, A. Terbuch, et al. · Annals of Oncology · 43
PDF
Feasibility and acceptability of a remotely‐delivered behavioural health coaching intervention to limit gestational weight gain
2020 · J. W. Coughlin, L. M. Martin, et al. · Obesity Science & Practice · 21
PDF
Family History of Prostate, Breast, Ovarian, and/or Pancreatic Cancer and Associations with Grade Reclassification in a Large Prostate Cancer Active Surveillance Cohort
2025 · Claire M. de la Calle, Yuezhou Jing, et al. · European Urology Oncology
Pd26-08 Impact of High-risk Family History on Upgrading During Active Surveillance for Grade Group 1 Prostate Cancer—results From the Johns Hopkins Active Surveillance Registry
2024 · Julia C. Fountain, Claire M. de la Calle, et al. · The Journal of Urology
Mp38-06 Impact of Three Measures of Inherited Prostate Cancer Risk on Upgrading During Active Surveillance for Grade Group 1 Prostate Cancer
2023 · Claire De La Calle, Julia Fountain, et al. · The Journal of Urology
Works count: 8
Citation count: 203
H-index: 4
I10-index: 4
Year
Topic
Type